Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $4.38 million as of August 15, 2025. Its market cap has decreased by -12.99% in one year.

Market Cap

4.38M

Enterprise Value

7.03M

Revenue

45.45M

Ranking

n/a

PE Ratio

6.42

Stock Price

$0.94

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 4.38M, a decrease of -98.03%. That is a compound annual growth rate of -13.41%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	4.38M	-63.12%
Dec 31, 2024	11.87M	152.98%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	12.69M	-33.55%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.72M
Veradigm	789.71M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	608.19M
Glass House Brands	543.74M
Northwest Biotherapeutics	349.08M
American Oncology Network	337.45M
CytoDyn	300.87M

Market Cap Rankings